AHK-CU is a copper-binding tripeptide used mainly in topical cosmetics. This page describes hypothesized and cosmetic effects, not established medical treatments, and systemic use is largely unstudied.
Overview
AHK-CU (alanyl-histidyl-lysine with copper) is a member of the copper-peptide family used chiefly in hair and skin cosmetics. Because copper peptides are discussed as carriers of copper and as signaling molecules for skin and follicles, most interest in AHK-CU centers on:
- Signaling to hair follicles in ways hypothesized to support hair growth.
- Delivering copper, a cofactor in several skin-relevant processes.
- Cosmetic effects on skin appearance and quality.
These are the themes explored in cosmetic and laboratory settings; they are not a promise of any specific medical result.
Hair-growth signaling
The most distinctive area of interest for AHK-CU is hair. It is discussed as a follicle-signaling peptide that is hypothesized to support the growth phase of the hair cycle and follicle size when applied topically.
- Hair-related signaling is the primary reason AHK-CU appears in serums.
- Observations come largely from cosmetic and laboratory work rather than large trials.
- It is not a recognized medical treatment for hair loss.
Skin appearance
As a copper peptide, AHK-CU is also discussed for skin, where copper's role in connective-tissue and remodeling processes underpins cosmetic claims about appearance and quality. This overlaps with the broader copper-peptide category and is framed in cosmetic terms rather than as treatment of any skin disease.
How AHK-CU compares to related peptides
AHK-CU is often discussed alongside other copper peptides, each with a different emphasis:
- GHK-Cu — the best-known copper tripeptide, emphasized for skin and wound-healing themes.
- Other copper complexes — share the copper-delivery concept but differ in the peptide backbone.
Relative to GHK-Cu, AHK-CU is discussed more specifically in the hair-growth context, though both rest primarily on cosmetic and preclinical evidence.
Evidence and caveats
Cosmetic interest is not the same as proven medical benefit. Key caveats:
- AHK-CU is not an approved drug for hair loss or any condition.
- Its evidence base is topical and cosmetic; systemic use is largely unstudied.
- Follicle-level or laboratory signals do not guarantee visible, durable results.
- Product quality varies, especially outside regulated cosmetic channels.